Leadership change ahead for Oxford Nanopore
Financial Times (FT) - 11-Aug-2025Gordon Sanghera to leave after 20 years as takeover interest grows in UK DNA sequencing firm
Join the club for FREE to access the whole archive and other member benefits.
Gordon Sanghera to leave after 20 years as takeover interest grows in UK DNA sequencing firm
Her focus is on reversing disease through cellular rejuvenation
Basecamp expands AI and genetic tools to create fast, programmable gene therapies
Goal is to develop drugs that target epigenetic mechanisms associated with neurodegeneration
Mitch Scanlan brings extensive industry experience to lead Biogelx’s expansion of hydrogels
No resources found!
No blog posts found!